early prostate cancer protein blood levels elevated prostate cancer appears provide accuracy identifying early prostate cancer standard prostate cancer marker psa name gene gets name second prostate cancer marker identified research team earlier marker previously known called leman getzenberg colleagues describe april issue urology performance characteristic novel nuclear protein marker prostate cancer cells paper since retracted study initiated suggested protein serum assay exhibits favorable performance characteristics potentially superior serum psa however studies necessary see test retain sensitivity used screening populationcitation needed september industry sponsor onconome sued dr robert getzenberg jhu university pittsburgh previous institution claiming getzenberg misrepresented falsified data related onconome sponsored million dollars research five years getzenbergs labs university pittsburgh johns hopkins blood test prostate cancer onconome claimed test essentially reliable flipping coin robert h getzenberg phdjhu first developed graduate student professor donald coffey johns hopkins later faculty member university pittsburgh getzenberg former professor urology director research james buchanan brady urological institute left johns hopkins university school medicine undisclosed